The team that was banned by the SEC for the troubled C3 International deal, is already back with a new variation called C3 Pharmaceuticals. It’s the same executives and the same drug, but with a slightly different name planning to list on the Canadian Securities Exchange. The new iteration of C3 Pharmaceuticals, …
Tag: Investing
High Tide fine-tunes playbook as Canadian cannabis rivals struggle
Calgary-based High Tide Inc. (Nasdaq: HITI) (TXSV: HITI) continues to grow its store count alongside its balance sheet, all while some of its largest competitors file for bankruptcy or shutter locations amid industry headwinds. On an earnings call Monday, High Tide CEO Raj Grover said the company has opened 21 …
The Daily Hit: September 17, 2024
The Daily Hit is a recap of the top financial news stories for Tuesday, September 17, 2024. On the Site DEA acknowledges new standard for designating medical value of drugs The new two-step test was initiated by the U.S. Department of Health and Human Services during its evaluation of cannabis …
DEA acknowledges new standard for designating medical value of drugs
In a move that could have ramifications both for marijuana rescheduling and psychedelics in the future, the U.S. Drug Enforcement Administration this week apparently acknowledged that the five-factor test it had used for years to determine whether a given drug had any accepted medical value is now outdated and is …